Evaluation of Exosomes Injection in Treatment of Male Androgenetic Alopecia: Clinical and Immunohistochemical Study

Phase 2Not Yet RecruitingNCT07112586

Ain Shams University15 enrolled

Overview

Intradermal injection of exosomes in treatment of male androgenetic alopecia, clinically and using a immunohistochemical marker

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Androgenetic Alopecia

Interventions

Plasma derived exosomesDRUG

Exosomes derived from patients' plasma, centrifuged at high speeds multiple times

Eligibility

Sex: MALEMin age: 18 YearsMax age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: \- Androgenetic Alopecia Grades 1-4 Exclusion Criteria: * blood diseases Receiving other treatments History of malignancy or allergic reaction to exosomes

Locations (1)

Ain Shams Univeristy Faculty of medicine

Cairo, Abbasia, Egypt

Outcomes

Primary Outcomes

Terminal to vellus hair ratio improvement

Counting the terminal and vellus hair counts and calculating the ratio, and comparing it between different study sessions and at follow-ups

Time frame: One year

Central Contacts

Dana Ashraf Maher, Assistant lecturer

CONTACT

+20 1225077011 dana.maher1@outlook.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.